See related Bonefos cap information |
|
Manufacturer |
Bayer |
Distributor |
Hong Kong: Zuellig/Macau: Firma Chun Cheong |
Contents |
Disodium clodronate |
Indications |
Treatment of osteolysis/hypercalcemia due to malignancy.
Click to view Bonefos detailed prescribing infomation |
Dosage |
1.6-2.4 g/day in 2-3 doses. Hypercalcemia, osteolytic bone metastases w/ osteolytic lesions 1.6-3.2 g/day.
Click to view Bonefos detailed prescribing infomation |
Overdosage |
View Bonefos overdosage for action to be taken in the event of an overdose. |
Administration |
Should be taken on an empty stomach (Take w/ full glass of plain water at least 1 hr before & 2 hr after eating, drinking (except plain water) or taking other oral drugs. Swallow whole, do not chew/crush.). |
Contraindications |
[Click for Bonefos detailed prescribing infomation] |
Special Precautions |
Renal dysfunction. Pregnancy & lactation.
Click to view Bonefos detailed prescribing infomation |
Adverse Drug Reactions |
Mild GI irritation.
View ADR Monitoring Form |
Drug Interactions |
Food, antacids & drugs containing Fe, Mg or manganese.
View more drug interactions with Bonefos |
Storage |
View Bonefos storage conditions for details to ensure optimal shelf-life. |
Description |
View Bonefos description for details of the chemical structure and excipients (inactive components). |
Mechanism of Action |
View Bonefos mechanism of action for pharmacodynamics and pharmacokinetics details. |
ATC Classification |
M05BA02 - clodronic acid ; Belongs to the class of bisphosphonates. Used in the treatment of bone diseases. |
Presentation/Packing |
Form |
Packing |
Photo |
Bonefos capsule |
|
|
Manufacturer: |
Bayer |
Distributor: |
Hong Kong: Zuellig
Macau: Firma Chun Cheong |
|
|
|
|